by Walter Gunzburg | Mar 2, 2023 | News, Press Release
This press release can be viewed online at: https://www.einpresswire.com/article/619655265 Checkmate Capital makes preferred equity investment in Austrianova parent company SGAustria for GMP facility expansion SINGAPORE, March 1, 2023 /EINPresswire.com/ — SG...
by Walter Gunzburg | Apr 23, 2022 | Press Release
SINGAPORE, April 21st, 2022Austrianova (the SG Austria group, Austrianova Singapore and Austrianova Thailand) is pleased to announce that it has been awarded ISO 9001:2015 certification for the production of encapsulated and non-encapsulated cells at its facility in...
by Walter Gunzburg | Jul 7, 2021 | Press Release
SINGAPORE, July 7th, 2021 Austrianova (the SG Austria group, Austrianova Singapore and Austrianova Thailand) is pleased and honoured to announce that, after extensive due diligence, Real Tech Fund (managed by Real Tech Holdings, Japan) has invested an undisclosed...
by Walter Gunzburg | Apr 22, 2021 | Press Release
Singapore based Company envisages going public via SPAC merger or traditional IPO SINGAPORE, April 22, 2021 Austrianova (the SG Austria group, Austrianova Singapore and Austrianova Thailand) is pleased to announce that it has signed an Agreement with GEM Global...
by Walter Gunzburg | Nov 30, 2020 | Press Release
Austrianova announced today that a key publication on the ability of its patented technology, Bac-in-a-Box, to completely protect probiotics from acidic conditions found in the stomach has been published in the well respected journal “Microbial Cell Factories”...
by Walter Gunzburg | Jul 28, 2020 | Press Release
S.E. Asian company, Austrianova, headquartered in Singapore, announced today that it has filed a Drug Master File (DMF) with the U.S. Food and Drug Administration (FDA). This DMF provides all confidential and detailed information covering the production of...
